{"id":"NCT01363713","sponsor":"Santen Pharmaceutical Co., Ltd.","briefTitle":"A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis","officialTitle":"A Long-term Open-label Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis - Phase 3 -","status":"COMPLETED","phase":"PHASE3","dates":{"start":null,"primaryCompletion":"2012-09","completion":null,"firstPosted":"2011-06-01","resultsPosted":"2014-09-23","lastUpdate":"2014-10-06"},"enrollment":130,"design":{"allocation":null,"model":null,"masking":null,"primaryPurpose":null},"conditions":["Allergic Conjunctivitis"],"interventions":[{"type":"DRUG","name":"DE-114 ophthalmic solution","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"}],"summary":"Safety and efficacy of DE-114 ophthalmic solution will be evaluated in patients with allergic conjunctivitis, in an open-label, multicenter study.","primaryOutcome":{"measure":"Change in Ocular Itching Score by Visit","timeFrame":"From baseline to 8-week","effectByArm":[{"arm":"DE-114 Ophthalmic Solution","deltaMin":-0.6,"sd":0.1}],"pValues":[]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":1,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":130},"commonTop":["Nasopharyngitis"]}}